<DOC>
	<DOCNO>NCT01079663</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Chlorhexidine Gluconate chip ( Periochip® ) versus Placebo Chip treatment symptom patient Peri-Implantitis .</brief_summary>
	<brief_title>The Efficacy Safety Chlorhexidine Gluconate Chip ( Periochip® ) Therapy Symptoms Patients With Peri-implantitis</brief_title>
	<detailed_description />
	<mesh_term>Peri-Implantitis</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>1 . Signed date Informed Consent Form . 2 . Good general health . 3 . Male female patient age &gt; 21 year old . 4 . Availability 25 week duration study . 5 . Periimplantitis characterized presence least 1 implant periodontal pocket 610 mm depth ( potential target implant ) demonstrate Bleeding Probing without involve apex implant confirm radiographically . 6 . Females childbearing potential must nonpregnant nonlactating entry agree use adequate method birth control study . 1 . Presence oral local mechanical factor could ( opinion Investigator ) influence outcome study . 2 . Presence orthodontic appliance , removable appliance , impinges tissue assess . 3 . Presence soft hard tissue tumours oral cavity . 4 . Horizontal inter implant distance ≤2 mm ( adjacent implant exists ) . 5 . Selection follow dental implant type target implant/s : hydroxylapatite ( HA ) and/or Titanium Plasmasprayed ( TPS ) . 6 . History allergy Chlorhexidine . 7 . Patients treat systemic antibiotic therapy periodontal/mechanical/local delivery therapy within 6 week prior study entry throughout study duration . 8 . Patients treat nonsteroidal antiinflammatory drug ( NSAIDs ) within 14 day prior entry study throughout study duration ( exclude treatment acetylsalicylic acid ≤100 mg /day ) . 9 . Patients take Phenytoin , calcium channel blocker drug ( CCBs ) and/or cyclosporine , might influence pattern tissue response . 10 . Presence follow condition : Type 1 diabetes , major recurrent aphtae stomatitis , abscess related oral pathology . 11 . The presence medical psychiatric condition condition , opinion Investigator , could affect successful participation patient study . 12 . Patient participate clinical study 30 day prior start study throughout study duration . 13 . Patient us Chlorhexidine oral rinses/ mouthwash regular basis .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>